Published in Eur J Gastroenterol Hepatol on July 01, 2008
Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int (2011) 1.15
Principles and clinical application of ultrasound elastography for diffuse liver disease. Ultrasonography (2014) 1.11
Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Can J Gastroenterol (2010) 1.02
Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice. Postgrad Med J (2013) 0.80
A learning curve assessment of real-time sonoelastography of the prostate. World J Urol (2012) 0.79
Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)). World J Gastroenterol (2015) 0.77
Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography. Int J Hepatol (2015) 0.75
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology (2007) 3.75
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology (2004) 3.04
Sources of variability in histological scoring of chronic viral hepatitis. Hepatology (2005) 2.64
A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology (2005) 2.38
Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial. Clin Gastroenterol Hepatol (2007) 2.08
Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol (2010) 1.94
Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive. Hepatology (2012) 1.94
Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol (2002) 1.81
A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol (2011) 1.79
Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology (2013) 1.64
Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C. Hepatology (2008) 1.62
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int (2008) 1.62
Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem (2007) 1.57
Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med (2003) 1.55
Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology (2002) 1.55
Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit Care Med (2009) 1.51
Percutaneous radiologic gastrostomy versus nasogastric tube in critically ill patients. Clin Nutr (2005) 1.40
Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology (2003) 1.39
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol (2002) 1.32
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg (2010) 1.28
Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol (2008) 1.21
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One (2012) 1.17
Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ (2006) 1.10
Inter-observer and intra-observer variability in hepatology. Eur J Gastroenterol Hepatol (2003) 1.10
Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. Hepatology (2015) 1.08
Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care (2010) 1.08
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Ann Intern Med (2013) 1.02
Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem (2008) 1.01
Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World J Biol Psychiatry (2003) 0.99
The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int (2009) 0.97
New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol (2004) 0.95
Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology (2014) 0.95
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J Hepatol (2006) 0.94
[Non-invasive diagnosis of portal hypertension in cirrhosis. Application to the primary prevention of varices]. Gastroenterol Clin Biol (2005) 0.92
IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology (2014) 0.91
Vascular involvement of the liver in Turner's syndrome. Hepatology (2004) 0.91
Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension. Hepatol Int (2008) 0.90
Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C. BMC Gastroenterol (2011) 0.90
First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis. Ann Pharmacother (2010) 0.90
Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol (2008) 0.89
Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci (2007) 0.89
A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. Hepatology (2003) 0.89
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol (2009) 0.89
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. Liver Int (2006) 0.87
Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter. Hum Gene Ther (2008) 0.87
Optimization and robustness of blood tests for liver fibrosis and cirrhosis. Clin Biochem (2010) 0.87
Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease. Liver Int (2010) 0.87
Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. Gastroenterology (2007) 0.85
Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL™ 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network. Health Qual Life Outcomes (2013) 0.85
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. J Clin Virol (2009) 0.83
Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis. World J Gastroenterol (2010) 0.83
Noninvasive liver steatosis quantification using MRI techniques combined with blood markers. Eur J Gastroenterol Hepatol (2010) 0.83
Evaluation of Baveno recommendations for grading esophageal varices. J Hepatol (2003) 0.82
Factors limiting complete tumor ablation by radiofrequency ablation. Cardiovasc Intervent Radiol (2007) 0.82
Renal macro- and microcirculation autoregulatory capacity during early sepsis and norepinephrine infusion in rats. Crit Care (2013) 0.81
Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model. PLoS One (2011) 0.81
Controlled attenuation parameter (CAP): a new device for fast evaluation of liver fat? Liver Int (2012) 0.81
Late onset of Wilson's disease in a family with genetic haemochromatosis. Eur J Gastroenterol Hepatol (2006) 0.80
Improved fibrosis staging by elastometry and blood test in chronic hepatitis C. Liver Int (2013) 0.80
Direct percutaneous approach for endoluminal glue embolization of stomal varices. J Vasc Interv Radiol (2008) 0.79
Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World J Gastroenterol (2006) 0.79
Clinical interpretation of Fibroscan® results: a real challenge. Liver Int (2010) 0.79
Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease. J Pathol (2003) 0.79
[Hepatosplenic localization of cat scratch disease in immunocompetent adults. Two cases]. Gastroenterol Clin Biol (2003) 0.78